PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A proprietary combination (Urox) containing Crataeva nurvala stem bark was evaluated for reducing symptoms, though specific efficacy results for the combination were not detailed in the abstract [PMID:29385990]
Bark decoction reduced the elevation of glycolate oxidase and lowered the deposition of stone-forming constituents in rat kidneys [PMID:2335959, PMID:22131740]
Ethanolic extracts of stem bark showed nootropic activity against scopolamine-induced impairment in rats [PMID:27065767]
Ethanol extract of bark prevented kidney dysfunction and normalized uric acid, creatinine, and CK-MB activities in 2K1C rats [PMID:37593003]
Ethanolic bark extract demonstrated antioxidative potential against androgen-mediated oxidative stress in male rats [PMID:24082632]
Evidence summary
PubMed sources
- 1.PMID: 37110691 (2023) — In Vivo Neuropharmacological Effects of Neophytadiene. · Molecules (Basel, Switzerland)
- 2.PMID: 37593003 (2023) — Crataeva nurvala Bark (Capparidaceae) Extract Modulates Oxidative Stress-Related Gene Expression, Restores Antioxidant Enzymes, and Prevents Oxidative Stress in the Kidney and Heart of 2K1C Rats. · Evidence-based complementary and alternative medicine : eCAM
- 3.PMID: 24082632 (2012) — Modulatory effects of Crataeva nurvala bark against testosterone and N-methyl-N-nitrosourea-induced oxidative damage in prostate of male albino rats. · Pharmacognosy magazine
- 4.PMID: 27065767 (2015) — Nootropic activity of Crataeva nurvala Buch-Ham against scopolamine induced cognitive impairment. · EXCLI journal
- 5.PMID: 22131740